InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Handley Michael K, 董事长兼首席执行官. Officer active across 2 companies, notably Cytocom, Inc.. Cumulatively, 2 filings have been published. History available since 27 July 2021. The latest transaction was filed on 27 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Michael K. Handley is the President and CEO of Cytocom, Inc. He leads the company with a strategic vision focused on innovation and growth. Handley brings significant expertise in business management and product development, thus contributing to Cytocom's mission to provide advanced therapeutic solutions. His leadership is essential for navigating the dynamic biotechnology market.